A Study Evaluating the Effectiveness of PEA Compared to Placebo for Reducing Pain Severity and Duration of Migraines.

Exclusion Criteria

• •Use of long-term medication (unless for controlled medical condition as above)
• •Pregnant, trying to get pregnant or lactating women\^
• •Chronic past and/or current alcohol use (greater than 14 alcoholic drinks week)
• •Smokers
• •Allergic or hypersensitive to any of the ingredients in the active or placebo formula
• •Use of preventative migraine medication
• •Migraines that have reported:
• •* To occur on 15 or more days/month for more than 3 months, which, on at least 8 days/month, has the features of migraine headache.
• •* A debilitating attack lasting for more than 72 hours.
• •* A seizure
• •* A medical condition will be considered uncontrolled if the participant reports ongoing treatment, a change of either medication type or dose in the past 3 months or any change in symptoms within the past 3 months.
• •* Any person suspecting they may be pregnant (e.g. missed period, nausea, fatigue) will be directed to attend their GP for a pregnancy test prior to enrolment in the trial.